Exact Mass: 377.097144

Exact Mass Matches: 377.097144

Found 33 metabolites which its exact mass value is equals to given mass value 377.097144, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole

4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine

C21H16FN3OS (377.0998058)


   

N-Hbgd

6-({[4-(hydroxymethyl)phenyl]methyl}[sulphanyl(carbonothioyl)]amino)hexane-1,2,3,4,5-pentol

C15H23NO6S2 (377.0966738)


   

S-Pyruvylglutathione

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-oxopropanoyl)sulphanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C13H19N3O8S (377.0892814)


   

Maybridge1_000863

Maybridge1_000863

C21H16FN3OS (377.0998058)


   

Oxychelirubine

Oxychelirubine

C21H15NO6 (377.08993300000003)


   

Asp Asp Glu

Asp Asp Glu

C13H19N3O10 (377.10703939999996)


   

Glu Asp Asp

Glu Asp Asp

C13H19N3O10 (377.10703939999996)


   

SB 203580

4-[4-(4-fluorophenyl)-2-[4-methylsulfinyl)phenyl]-1H-imidazol-5-yl]-pyridine

C21H16FN3OS (377.0998058)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents C308 - Immunotherapeutic Agent D004791 - Enzyme Inhibitors

   

12-Hydroxychelirubine

12-Hydroxychelirubine

C21H15NO6 (377.08993300000003)


   

Asp Glu Asp

Asp Glu Asp

C13H19N3O10 (377.10703939999996)


   

S-Pyruvylglutathione

S-Pyruvylglutathione

C13H19N3O8S (377.0892814)


   

Asn-His-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-4-(1H-imidazol-4-yl)butanoic acid

C15H15N5O7 (377.097144)


   

Omeprazole Sulfone N-Oxide

Omeprazole Sulfone N-Oxide

C17H19N3O5S (377.10453640000003)


   

2-Carboxy-5-fluoro-1-[(1-naphthalenyl)methyl]-1H-indole-3-acetic acid

2-Carboxy-5-fluoro-1-[(1-naphthalenyl)methyl]-1H-indole-3-acetic acid

C22H16FNO4 (377.1063308)


   

2-BROMO-6-IODO-3-METHOXYPYRIDINE

2-BROMO-6-IODO-3-METHOXYPYRIDINE

C22H16FNO4 (377.1063308)


   

tert-Butyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

tert-Butyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

C19H24BrNO2 (377.0990304)


   

Ronifibrate

3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl pyridine-3-carboxylate

C19H20ClNO5 (377.1029940000001)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates

   

4,4,4-Nitrilotribenzoic acid

4,4,4-Nitrilotribenzoic acid

C21H15NO6 (377.08993300000003)


   

ERRα antagonist-1

ERRα antagonist-1

C21H19N3S2 (377.10203340000004)


   

Pyridine, 4-(4-(4-fluorophenyl)-2-(5-((R)-methylsulfinyl)phenyl)-1H-imidazol-4-yl)-

Pyridine, 4-(4-(4-fluorophenyl)-2-(5-((R)-methylsulfinyl)phenyl)-1H-imidazol-4-yl)-

C21H16FN3OS (377.0998058)


   

Glufanide disodium

Glufanide disodium

C16H17N3Na2O5 (377.0963552)


D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D020011 - Protective Agents > D000931 - Antidotes C308 - Immunotherapeutic Agent D007155 - Immunologic Factors

   

Acridine half-mustard

Acridine half-mustard

C19H21Cl2N3O (377.1061596)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D009153 - Mutagens

   

[2-Amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-A]pyridin-3-YL]-phenyl-methanone

[2-Amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-A]pyridin-3-YL]-phenyl-methanone

C21H13F2N3O2 (377.09757820000004)


   

4,5-Dihydrofarnesyl diphosphate

4,5-Dihydrofarnesyl diphosphate

C15H23O7P2-3 (377.0918968)


   

S-lactoylgluta-thione

S-lactoylgluta-thione

C13H19N3O8S (377.0892814)


   

Glu-Asp-Asp

Glu-Asp-Asp

C13H19N3O10 (377.10703939999996)


   

4-benzyl-N-(3,5-dichlorophenyl)-1,4-diazepane-1-carboxamide

4-benzyl-N-(3,5-dichlorophenyl)-1,4-diazepane-1-carboxamide

C19H21Cl2N3O (377.1061596)


   

1,3-Benzodioxol-5-yl 4-(diethylsulfamoyl)benzoate

1,3-Benzodioxol-5-yl 4-(diethylsulfamoyl)benzoate

C18H19NO6S (377.0933034)


   

3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide

3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide

C20H15N3O5 (377.10116600000003)


   

2-[[2-Oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid

2-[[2-Oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid

C15H18F3N3O3S (377.10209140000006)


   

Asp-Glu-Asp

Asp-Glu-Asp

C13H19N3O10 (377.10703939999996)


   

Asp-Asp-Glu

Asp-Asp-Glu

C13H19N3O10 (377.10703939999996)


   

Adaptaquin

Adaptaquin

C21H16ClN3O2 (377.0930986)


Adaptaquin is an inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 (HIF-PHD2), with an IC50 of 2 μM. Adaptaquin can inhibit lipid peroxidation and maintain mitochondrial function[1][2].